Shaofa Xu

1.7k total citations · 1 hit paper
28 papers, 1.2k citations indexed

About

Shaofa Xu is a scholar working on Surgery, Epidemiology and Infectious Diseases. According to data from OpenAlex, Shaofa Xu has authored 28 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 10 papers in Epidemiology and 9 papers in Infectious Diseases. Recurrent topics in Shaofa Xu's work include Tuberculosis Research and Epidemiology (9 papers), Lung Cancer Diagnosis and Treatment (7 papers) and Mycobacterium research and diagnosis (4 papers). Shaofa Xu is often cited by papers focused on Tuberculosis Research and Epidemiology (9 papers), Lung Cancer Diagnosis and Treatment (7 papers) and Mycobacterium research and diagnosis (4 papers). Shaofa Xu collaborates with scholars based in China, United States and India. Shaofa Xu's co-authors include Yu Pang, Guanglu Jiang, Xichao Ou, Daniel P. Chin, Lixia Wang, Guangxue He, Hongtao Zhang, Qiang Li, Bing Zhao and Yuanyuan Song and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Shaofa Xu

28 papers receiving 1.1k citations

Hit Papers

National Survey of Drug-Resistant Tuberculosis in China 2012 2026 2016 2021 2012 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shaofa Xu China 14 728 589 421 166 115 28 1.2k
Digamber Behera India 25 846 1.2× 576 1.0× 313 0.7× 642 3.9× 183 1.6× 93 1.6k
Parvaneh Baghaei Iran 20 802 1.1× 628 1.1× 363 0.9× 76 0.5× 31 0.3× 76 1.0k
Christina Ha United States 22 130 0.2× 794 1.3× 538 1.3× 118 0.7× 323 2.8× 103 1.8k
Chi‐Chiu Leung China 18 618 0.8× 476 0.8× 242 0.6× 98 0.6× 63 0.5× 29 904
Dion Kramer United States 17 244 0.3× 249 0.4× 378 0.9× 130 0.8× 80 0.7× 49 1.1k
Randeep Guleria India 17 314 0.4× 251 0.4× 133 0.3× 363 2.2× 124 1.1× 82 1.0k
Jae Seuk Park South Korea 16 628 0.9× 503 0.9× 269 0.6× 40 0.2× 160 1.4× 59 896
Rupak Singla India 17 582 0.8× 454 0.8× 292 0.7× 108 0.7× 49 0.4× 51 789
C Wendy Spearman South Africa 20 247 0.3× 798 1.4× 212 0.5× 40 0.2× 114 1.0× 89 1.4k
Jennifer deBruyn Canada 19 194 0.3× 1.1k 1.8× 732 1.7× 46 0.3× 146 1.3× 57 2.0k

Countries citing papers authored by Shaofa Xu

Since Specialization
Citations

This map shows the geographic impact of Shaofa Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaofa Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaofa Xu more than expected).

Fields of papers citing papers by Shaofa Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shaofa Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaofa Xu. The network helps show where Shaofa Xu may publish in the future.

Co-authorship network of co-authors of Shaofa Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Shaofa Xu. A scholar is included among the top collaborators of Shaofa Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shaofa Xu. Shaofa Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Han, Yi, Ziwei Xu, Yushan Zhang, et al.. (2022). Identification of solamargine as a cisplatin sensitizer through phenotypical screening in cisplatin-resistant NSCLC organoids. Frontiers in Pharmacology. 13. 802168–802168. 16 indexed citations
3.
Liu, Wei, Wang Fei, Ding Zhang, et al.. (2022). Effect of Preoperative Thoracic Paravertebral Blocks on Emergence Agitation During Tracheal Extubation: A Randomized Controlled Trial. Frontiers in Medicine. 9. 902908–902908. 3 indexed citations
4.
Liu, Wei, Wang Fei, Hongtao Zhang, et al.. (2022). The Effects of Programmed Intermittent Paravertebral Bolus Infusion on Postoperative Analgesia in Patients Undergoing Video-Assisted Thoracoscopic Surgery: A Prospective, Randomized, Controlled Study. Journal of Cardiothoracic and Vascular Anesthesia. 36(9). 3637–3644. 8 indexed citations
5.
Liu, Yuhong, Jingtao Gao, Jian Du, et al.. (2020). Acquisition of clofazimine resistance following bedaquiline treatment for multidrug-resistant tuberculosis. International Journal of Infectious Diseases. 102. 392–396. 19 indexed citations
6.
Cui, Yong, et al.. (2018). Acute attack of recurrent esophageal duplication cyst in an adult: case report and literature review. Journal of Thoracic Disease. 10(5). E335–E339. 5 indexed citations
7.
Huang, Shaojun, Xianhua Wang, Zhidong Liu, et al.. (2016). Vitamin D deficiency and the risk of tuberculosis: a meta-analysis. Drug Design Development and Therapy. Volume11. 91–102. 121 indexed citations
9.
Zhou, Shijie, Yi Han, Daping Yu, et al.. (2015). Sleeve lobectomy by video-assisted thoracic surgery versus thoracotomy for non-small cell lung cancer. Journal of Cardiothoracic Surgery. 10(1). 116–116. 38 indexed citations
10.
Sun, Zhaogang, Weimin Li, Shaofa Xu, & Hairong Huang. (2015). The discovery, function and development of the variable number tandem repeats in differentMycobacteriumspecies. Critical Reviews in Microbiology. 42(5). 1–21. 8 indexed citations
11.
Sun, Zhaogang, Yuhui Xu, Zhi‐Ling Li, et al.. (2015). Discrepancies in Drug Susceptibility Test for Tuberculosis Patients Resulted from the Mixed Infection and the Testing System. BioMed Research International. 2015. 1–7. 7 indexed citations
12.
Zhang, Xia, Fei Liu, Qi Li, et al.. (2014). A proteomics approach to the identification of plasma biomarkers for latent tuberculosis infection. Diagnostic Microbiology and Infectious Disease. 79(4). 432–437. 13 indexed citations
13.
Du, Jian, Yu Pang, Yuhong Liu, et al.. (2014). Survey of Tuberculosis Hospitals in China: Current Status and Challenges. PLoS ONE. 9(11). e111945–e111945. 18 indexed citations
15.
Sun, Jiayang, Lei Shi, Xudong Gao, & Shaofa Xu. (2012). Physical Activity and Risk of Lung Cancer: A Meta-Analysis of Prospective Cohort Studies. Asian Pacific Journal of Cancer Prevention. 13(7). 3143–3147. 39 indexed citations
16.
Zhao, Yanlin, Shaofa Xu, Lixia Wang, et al.. (2012). National Survey of Drug-Resistant Tuberculosis in China. New England Journal of Medicine. 366(23). 2161–2170. 491 indexed citations breakdown →
17.
Yue, Wentao, Xiaoting Zhao, Lína Zhang, et al.. (2011). Cell Cycle Protein Cyclin Y Is Associated With Human Non–Small-Cell Lung Cancer Proliferation and Tumorigenesis. Clinical Lung Cancer. 12(1). 43–50. 29 indexed citations
18.
Sun, Tiansheng, et al.. (2010). The clinical study of repairing cauda equina fibres with fibrin glue after lumbar fracture and dislocation. Spinal Cord. 48(8). 633–637. 4 indexed citations
19.
Yue, Wentao, et al.. (2010). [Detecting EGFR autoantibodies in serums of NSCLC patients with peptide array].. PubMed. 13(7). 727–30. 2 indexed citations
20.
Chen, Ke‐Neng, et al.. (2006). Surgical Treatment of Complex Malignant Anterior Mediastinal Tumors Invading the Superior Vena Cava. World Journal of Surgery. 30(2). 162–170. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026